Document is current
Any future updates will be listed below
-
Authors
Tober, Romy
Schnetzke, Ulf
Fleischmann, Maximilian
Yomade, Olaposi
Schrenk, Karin
Hammersen, Jakob
Glaser, Anita
Thiede, Christian
Hochhaus, Andreas
Scholl, Sebastian https://orcid.org/0000-0003-2893-3630
-
Funding
Funding for this research was provided by:
Universitätsklinikum Jena
- License Information
-
More Information
Article History
Received: 21 February 2022
Accepted: 23 March 2022
First Online: 18 May 2022
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. The authors have no conflicts of interest to declare that are relevant to the content of this article. The authors have no financial or proprietary interests in any material discussed in this article.
: The presented study does not include research involving animals or pharmacological research in human participants. The presented retrospective study was performed according to the Declaration of Helsinki.
: All patients were included in the SAL registry (Study Alliance Leukemia). Patients gave their written informed consent for data acquisition and analysis after pseudonymization in the AML registry. The participation in this AML registry and the clinical analyses presented in this manuscript have been approved by the Ethical review committee of the University Hospital Jena.
